5AM Ventures
Overview
5AM Ventures is a California-based venture capital firm that aims to finance seed- and early-stage life sciences companies.
Investment Focus
- Focus on early-stage life science companies
- Preference for Series A investments
- Interest in biopharmaceuticals, drug delivery technologies, and life science instruments
Portfolio Companies
Get the full list of 54,000+ investors
5AM Ventures and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about 5AM Ventures
What sectors does 5AM Ventures invest in?
5AM Ventures invests in Life Sciences, Biotechnology and Health Tech, and is based in Menlo Park, California, United States. 5AM Ventures is listed as a vc in the ConnectSafely investor database.
What stage does 5AM Ventures invest at?
5AM Ventures backs companies at Seed, Series A, Series B and Growth, writing cheques of 5M - 20M.
Which regions does 5AM Ventures invest in?
5AM Ventures invests across United States, United Kingdom and Switzerland.
Who are the partners at 5AM Ventures?
Team members listed for 5AM Ventures include John Diekman (Founding and Managing Partner) and Kush M Parmar (Managing Partner).
What companies has 5AM Ventures invested in?
5AM Ventures's portfolio includes Ensoma, Homology Medicines, Arvinas, CinCor Pharma, CAMP4 Therapeutics, Surrozen, Latigo Biotherapeutics and GlycoEra.
How do I contact 5AM Ventures?
5AM Ventures's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
